Rfp Financial Group LLC Cyto Dyn Inc. Call Options Transaction History
Rfp Financial Group LLC
- $282 Million
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding CYDY
# of Institutions
9Shares Held
406KCall Options Held
0Put Options Held
0-
Eagle Bay Advisors LLC New York, NY162KShares$19,4530.01% of portfolio
-
Mai Capital Management47.5KShares$5,6970.0% of portfolio
-
Diversified Trust CO45.8KShares$5,4940.0% of portfolio
-
Williams Jones Wealth Management, Llc. New York, NY45KShares$5,4000.0% of portfolio
-
Next Capital Management LLC32.5KShares$3,9000.0% of portfolio
About CytoDyn Inc.
- Ticker CYDY
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 813,040,000
- Market Cap $97.6M
- Description
- CytoDyn Inc. operates as a clinical-stage biotechnology company. The company focuses on developing treatments for multiple therapeutic indications based on leronlimab, a novel humanized monoclonal antibody targeting the CCR5 receptor in the areas of human immunodeficiency virus (HIV), non-alcoholic steatohepatitis (NASH), oncology, and such as c...